Fundz

Yarrow Bioscience, Inc. Completes Merger with Yarrow Bioscience Operating Company Corp.

PUBLIC · YARWSep 10, 2026

Acquiring Company

Yarrow Bioscience

Acquired Company

Yarrow Bioscience Operating Company

New HavenNew HavenBiotechnologyHealthcareHealth CareTherapeuticsBiotechnologyHealth Care

Description

On September 10, 2026, Yarrow Bioscience, Inc. announced the completion of its merger with Yarrow Bioscience Operating Company Corp. This merger is a pivotal step in their strategic growth, allowing them to streamline operations and enhance their market presence in the biosciences sector. Following the merger, the company is expected to focus on advancing its innovative product development.

Who to call at Yarrow Bioscience, and when

When Yarrow Bioscience changes hands, the new owners review vendors, systems and leadership. That is when the door opens.

  • An alert the day Yarrow Bioscience raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Yarrow Bioscience, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Yarrow Bioscience. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Yarrow Bioscience

Location

New Haven, Connecticut, United States

About

Yarrow Bioscience, Inc. is a biotechnology company focused on developing novel therapies for autoimmune diseases. Founded by RTW Investments, Yarrow is advancing its lead program, YB-101, which targets thyroid-stimulating hormone receptors for the treatment of Graves' disease and thyroid eye disease. The company aims to address significant unmet needs in these therapeutic areas.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Yarrow Bioscience makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Igor
Senior decision-maker at this company
••••••••@••••••••

See Igor's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Yarrow Bioscience's next move

Learn about Strategic plan

Frequently asked

Who acquired Yarrow Bioscience Operating Company?

Yarrow Bioscience Operating Company was acquired by Yarrow Bioscience, based in New Haven. The deal was reported on September 10, 2026. Yarrow Bioscience, Inc. is a biotechnology company focused on developing novel therapies for autoimmune diseases. Yarrow Bioscience is publicly traded (YARW) and operates in Biotechnology.

When did Yarrow Bioscience acquire Yarrow Bioscience Operating Company?

Yarrow Bioscience's acquisition of Yarrow Bioscience Operating Company was reported on September 10, 2026. On September 10, 2026, Yarrow Bioscience, Inc. announced the completion of its merger with Yarrow Bioscience Operating Company Corp. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Yarrow Bioscience Operating Company do?

Previously known as Yarrow Bioscience, Inc., Yarrow Bioscience Operating Company Corp. is involved in the biosciences sector, aiming to enhance health and wellness through biotechnological innovations. It is privately held, operating in Biotechnology, and is based in New Haven.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.